Literature DB >> 19563413

Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels.

Naoto Kuroda1, Masato Tamura, Yukichi Tanaka, Ondrej Hes, Michal Michal, Kaori Inoue, Masahiko Ohara, Keiko Mizuno, Gang-Hong Lee.   

Abstract

Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion has been recently identified. Herein is presented a case of RCC with Xp11.2 translocations/TFE3 gene fusions with unusual histological findings. A 68-year-old Japanese woman was incidentally found to have a renal mass on CT. Histological examination showed clear cell neoplasm with alveolar and papillary growth patterns. The nuclear atypia corresponded to Fuhrman grade 3. Additionally, smooth muscle stroma was observed and abnormal vessels showing a heterogeniety in thickness were also identified. On immunohistochemistry, neoplastic cells were diffusely positive for transcription factor E3 (TFE3) and Melan A, and focally positive for CD10 and RCC marker. The smooth muscle stroma was positive for alpha-smooth muscle actin and h-caldesmon, but reverse transcription-polymerase chain reaction of the tumor using frozen material could not detect any previously reported chimeric transcripts including ASPL-TFE3, PRCC-TFE3, CLTC-TFE3, PSF-TFE3 or NoNo-TFE3. G-band karyotype was unsuccessful. Pathologists should pay attention to the afore-described unusual stromal reaction of adult-onset RCC associated with Xp11.2 translocations/TFE3 gene fusions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563413     DOI: 10.1111/j.1440-1827.2009.02398.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

1.  Re-evaluation of histological type by immunohistochemical and genetic study of transcription factors (TFE3 and TFEB) of VHL gene mutation-negative clear cell renal cell carcinoma and other special types of renal tumor.

Authors:  Naoto Kuroda; Chiaki Kawada; Kenji Tamura; Makoto Hiroi; Ondrej Hes; Michal Michal; Yukari Wada; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-03-23       Impact factor: 2.309

2.  Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma.

Authors:  Soo Hee Kim; Yoomi Choi; Hae Yeon Jeong; Kyoungbun Lee; Ji Youn Chae; Kyung Chul Moon
Journal:  Virchows Arch       Date:  2011-07-20       Impact factor: 4.064

3.  Xp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study.

Authors:  Hong Zou; Xueling Kang; Li-Juan Pang; Wenhao Hu; Jin Zhao; Yan Qi; Jianming Hu; Chunxia Liu; Hongan Li; Weihua Liang; Xianglin Yuan; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

4.  Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis.

Authors:  Yuqing Wu; Saisai Chen; Minhao Zhang; Kuangzheng Liu; Jibo Jing; Kehao Pan; Lihua Zhang; Bin Xu; Xiaoming Lu; Ming Chen
Journal:  Pathol Oncol Res       Date:  2021-03-30       Impact factor: 3.201

5.  Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion.

Authors:  Wenwu Ling; Xuelei Ma; Yan Luo; Linyan Chen; Huiyao Wang; Xiaoling Wang; Ni Chen; Hao Zeng; Yongzhong Li; Diming Cai
Journal:  Contrast Media Mol Imaging       Date:  2017-11-23       Impact factor: 3.161

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.